CASTLE BIOSCIENCES, INC. (CSTL)

Every figure this model derived for CSTL, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 43,123,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 259,991,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 341,100,000 AssetsCurrent 2026-06-30
current liabilities 56,509,000 LiabilitiesCurrent 2026-06-30
equity 470,030,000 StockholdersEquity 2026-06-30
interest expense 375,000 InterestExpenseNonoperating 2026-06-30
ocf 42,634,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 357,278,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 44,871,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CSTL on one particular measure came for.

RatioValue
cash operating margin7.94
current ratio6.04
current ratio reported6.04
deferred revenue growth-100.0
dilution pct-0.92
fcf margin-0.14
growth cv0.47
interest cover-85.62
operating margin-8.99
owner earnings margin-12.7
revenue growth3.18
revenue growth per share4.14
roic-11.35
rule of 40-5.81
sbc pct revenue12.56

What to be careful about

What this model itself distrusts about CSTL's figures. Written by the derivation as it ran, not added afterwards.